Literature DB >> 30387720

Functional Mixed-Effects Modeling of Longitudinal Duchenne Muscular Dystrophy Electrical Impedance Myography Data Using State-Space Approach.

Kush Kapur, Benjamin Sanchez, Adam Pacheck, Basil Darras, Seward B Rutkove, Rajesh Selukar.   

Abstract

OBJECTIVE: Electrical impedance myography (EIM) is a quantitative and objective tool to evaluate muscle status. EIM offers the possibility to replace conventional physical functioning scores or quality of life measures, which depend on patient cooperation and mood.
METHODS: Here, we propose a functional mixed-effects model using a state-space approach to describe the response trajectories of EIM data measured on 16 boys with Duchenne muscular dystrophy and 12 healthy controls, both groups measured over a period of two years. The modeling framework presented imposes a smoothing spline structure on EIM data collected at each visit and taking into account of within subject correlations of these curves along the longitudinal measurements. The modeling framework is recast in a state-space approach, thereby allowing for the employment of computationally efficient diffuse Kalman filtering and smoothing algorithms for the model estimation, as well as the estimates of the posterior variance-covariance matrix for the construction of the Bayesian [Formula: see text] confidence bands.
RESULTS: The proposed model allows us to simultaneously adjust for baseline variables, differentiate the longitudinal changes in the smooth functional response and estimate the subject and subject-time specific deviations from the population-averaged response curves. The code is made publicly available in the supplementary material. SIGNIFICANCE: The modeling approach presented will potentially enhance EIM capability to serve as a biomarker for testing therapeutic efficacy in DMD and other clinical trials.

Entities:  

Mesh:

Year:  2018        PMID: 30387720      PMCID: PMC6687059          DOI: 10.1109/TBME.2018.2879227

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  18 in total

1.  Functional mixed effects models.

Authors:  Wensheng Guo
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Wavelet-based functional mixed models.

Authors:  Jeffrey S Morris; Raymond J Carroll
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2006-04-01       Impact factor: 4.488

Review 3.  Experience and strategy for the molecular testing of Duchenne muscular dystrophy.

Authors:  Thomas W Prior; Scott J Bridgeman
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

4.  Reduced Rank Mixed Effects Models for Spatially Correlated Hierarchical Functional Data.

Authors:  Lan Zhou; Jianhua Z Huang; Josue G Martinez; Arnab Maity; Veerabhadran Baladandayuthapani; Raymond J Carroll
Journal:  J Am Stat Assoc       Date:  2010-03-01       Impact factor: 5.033

5.  Longitudinal functional principal component analysis.

Authors:  Sonja Greven; Ciprian Crainiceanu; Brian Caffo; Daniel Reich
Journal:  Electron J Stat       Date:  2010       Impact factor: 1.125

6.  Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy.

Authors:  Craig M Zaidman; Jim S Wu; Kush Kapur; Amy Pasternak; Lavanya Madabusi; Sung Yim; Adam Pacheck; Heather Szelag; Tim Harrington; Basil T Darras; Seward B Rutkove
Journal:  Ann Neurol       Date:  2017-05-04       Impact factor: 10.422

7.  FMEM: functional mixed effects modeling for the analysis of longitudinal white matter Tract data.

Authors:  Ying Yuan; John H Gilmore; Xiujuan Geng; Styner Martin; Kehui Chen; Jane-ling Wang; Hongtu Zhu
Journal:  Neuroimage       Date:  2013-09-25       Impact factor: 6.556

8.  The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.

Authors:  Craig M McDonald; Erik K Henricson; Jay J Han; R Ted Abresch; Alina Nicorici; Gary L Elfring; Leone Atkinson; Allen Reha; Samit Hirawat; Langdon L Miller
Journal:  Muscle Nerve       Date:  2010-04       Impact factor: 3.217

Review 9.  Emerging genetic therapies to treat Duchenne muscular dystrophy.

Authors:  Stanley F Nelson; Rachelle H Crosbie; M Carrie Miceli; Melissa J Spencer
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

Review 10.  Glucocorticoid corticosteroids for Duchenne muscular dystrophy.

Authors:  A Y Manzur; T Kuntzer; M Pike; A Swan
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  4 in total

1.  Modeling and simulation of needle electrical impedance myography in nonhomogeneous isotropic skeletal muscle.

Authors:  Xuesong Luo; Shaoping Wang; Benjamin Sanchez
Journal:  IEEE J Electromagn RF Microw Med Biol       Date:  2021-06-22

2.  Predicting myofiber cross-sectional area and triglyceride content with electrical impedance myography: A study in db/db mice.

Authors:  Sarbesh R Pandeya; Janice A Nagy; Daniela Riveros; Carson Semple; Rebecca S Taylor; Marie Mortreux; Benjamin Sanchez; Kush Kapur; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2020-10-28       Impact factor: 3.217

3.  Estimating myofiber cross-sectional area and connective tissue deposition with electrical impedance myography: A study in D2-mdx mice.

Authors:  Sarbesh R Pandeya; Janice A Nagy; Daniela Riveros; Carson Semple; Rebecca S Taylor; Marie Mortreux; Benjamin Sanchez; Kush Kapur; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2021-04-07       Impact factor: 3.852

4.  Electrical impedance myography for reducing sample size in Duchenne muscular dystrophy trials.

Authors:  Melanie L Leitner; Kush Kapur; Basil T Darras; Michele Yang; Brenda Wong; Laura Dalle Pazze; Julaine Florence; Martin Buck; Laura Freedman; Jose Bohorquez; Seward Rutkove; Craig Zaidman
Journal:  Ann Clin Transl Neurol       Date:  2019-12-25       Impact factor: 4.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.